Rick Winningham | Chief Executive Officer |
Brett Haumann | Chief Medical Officer |
Jessica Stitt | Vice President of Finance |
Alex Dobbin | Head of Investor Relations |
Louise Chen | Cantor |
Geoffrey Porges | SVB Leerink |
Alexander Duncan | Piper Jaffray |
Ladies and gentlemen, good afternoon. At this time, I would like to welcome everyone to the Theravance Biopharma Conference Call. [Operator Instructions] Today's conference call is being recorded. And now I’d like to turn the call over to Alex Dobbin, Head of Investor Relations. Please go ahead.